
    
      This is a blinded,single-dose,randomized,two-period,two-sequence,two-treatment,cross over
      study, designed to evaluate the comparative bioavailability of two formulations of erlotinib
      HCl 150mg tablets administered to healthy male and female subjects under fasting conditions.

      â€¢ SubjectswererandomlyassignedtooneofthetwodosingsequencesABorBA underfasting conditions.
    
  